Page 540 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

518 PART IV Specific Malignancies in the Small Animal Patient

148. Jafry Z, Gal A, Fleck A, et al.: Proposed expansion margins for 169. White R, Walker M, Legendre AM, et al.: Development of brachy-
planning organ at risk volume for senses during variation therapy therapy technique for nasal tumors in dogs, Am J Vet Res 51:1250–
of the nasal cavity in dogs and cats, Vet Radiol Ultrasound 58:471– 1256, 1990.
VetBooks.ir 149. Nagata K, Pethel T: A comparison of two dose calculation algo- 170. Thompson JP, Ackerman N, Bellah JR, et al.: 192 Iridium
478, 2017.
brachytherapy, using an intracavitary afterload device, for
rithms – anisotropic analytical algorithm and Acuros XB- for
radiation therapy planning of canine intranasal tumors, Vet Radiol treatment of intranasal neoplasms in dogs, Am J Vet Res 53:
617–622, 1992.
Ultrasound 58:479–485, 2017. 171. Withrow SJ: Cryosurgical therapy for nasal tumors in the dog, J Am
150. Martin A, Gaya A: Stereotactic body radiotherapy: a review, Clin Anim Hosp Assoc 18:585–589, 1982.
Oncol 22:157–172, 2010. 172. Murphy SM, Lawrence JA, Schmiedt CW, et al.: Image-guide
151. Kubicek L, Milner R, An Q, et al.: Outcomes and prognostic fac- transnasal cryoablation of a recurrent nasal adenocarcinoma in a
tors associated with canine sinonasal tumors treated with curative dog, J Small Anim Pract 52:329–333, 2011.
intent cone-based stereotactic radiosurgery (1999-2013), Vet Radiol 173. Lucroy MD, Long KR, Blaik MA, et al.: Photodynamic therapy for
Ultrasound 57:331–340, 2016. the treatment of intranasal tumors in 3 dogs and 1 cat, J Vet Intern
152. Glasser SA, Charney S, Dervisis NG, et al.: Use of an image-guided Med 17:727–729, 2003.
robotic radiosurgery system for the treatment of canine nonlym- 174. Osaki T, Takagi S, Hoshino Y, et al.: Efficacy of antivascular pho-
phomatous nasal tumors, J Am Anim Hosp Assoc 50:96–104, 2014. todynamic therapy using benzoporphyrin derivative monoacid ring
153. Gieger TL, Nolan MW: Linac-based stereotactic radiation therapy A (BPD-MA) in 14 dogs with oral and nasal tumors, J Vet Med Sci
for canine non-lymphmatous nasal tumours: 29 cases (2013-2016), 71:125–132, 2009.
Vet Comp Oncol 16:E68–75, 2018. 175. Maruo T, Nagata K, Fukuyama Y: Intraoperative acridine orange
154. Mellanby RJ, Stevenson RK, Herrtage ME, et al.: Long-term out- photodynamic therapy and cribriform electron-beam irradiation
come of 56 dogs with nasal tumours treated with four doses of for canine intrasnasal tumors: a pilot study, Can Vet J 56:1232–
radiation at intervals of seven days, Vet Rec 151:253–257, 2002. 1238, 2015.
155. Geiger T, Rassnick K, Siegel S, et al.: Palliation of clinical signs in 176. Fu D, Kato D, Watabe A, et al.: Prognostic utility of apoptosis
48 dogs with nasal carcinomas treated with coarse-fraction radia- index, Ki-67 and survivin expression in dogs with nasal carcinoma
tion therapy, J Am Anim Hosp Assoc 44:116–123, 2008. treated with orthovoltage radiation therapy, J Vet Med Sci 76:1505–
156. Maruo T, Shida T, Fukuyama Y, et al.: Retrospective study of 1512, 2014.
canine nasal tumor treated with hypofractionated radiotherapy, 177. Personal Communication, Stevens A, Turek M, Vail D, et al.:
J Vet Med Sci 73:193–197, 2011. Outcome of definitive-intent IMRT for stage 4 canine sinonasal
157. Tan-Coleman B, Lyons J, Lewis C, et al.: Prospective evaluation of tumors: 29 cases (2011-2017), Vet Cancer Soc Proc, 2018.
a 5 X 4 Gy prescription for palliation of canine nasal tumors, Vet 178. Thrall DE, Harvey CE: Radiotherapy of malignant nasal tumors in
Radiol Ultrasound 54:89–92, 2013. 21 dogs, J Am Vet Med Assoc 183:663–666, 1983.
158. Fujiwara A, Kobayashi T, Kazato Y, et al.: Efficacy of hypofrac- 179. Henderson SM, Bradley K, Day MJ, et al.: Investigation of nasal
tionated radiotherapy for nasal tumours in 38 dogs (2005-2008), disease in the cat—a retrospective study of 77 cases, J Feline Med
J Small Anim Pract 54:80–86, 2013. Surg 6:245–257, 2004.
159. Gieger T, Siegel S, Rosen K, et al.: Reirradiation of canine nasal 180. Mukaratirwa S, van der Linde-Sipman JS, Gruys E: Feline nasal
carcinomas treated with coarsely fractionated protocols: 37 cases, and paranasal sinus tumors: clinicopathological study, histomor-
J Am Anim Hosp Assoc 49:318–324, 2013. phological description and diagnostic immunohistochemistry of
160. Bommarito DA, Kent MS, Selting KA, et al.: Reirradiation of 123 cases, J Feline Med Surg 3:235–245, 2001.
recurrent canine nasal tumors, Vet Radiol Ultrasound 52:207–212, 181. Demko JL, Cohn LA: Chronic nasal discharge in cats: 75 cases
2011. (1993-2004), J Am Vet Med Assoc 230:1032–1037, 2007.
161. Rancilio NJ, Custead MR, Poulson JM: Radiation therapy com- 182. Theon AP, Peaston AE, Madewell BR, et al.: Irradiation of nonlym-
munication - Reirradation of a nasal tumor in a brachycephalic dog phoproliferative neoplasms of the nasal cavity and paranasal sinuses
using intensity modulated radiation therapy, Vet Radiol Ultrasound in 16 cats, J Am Vet Med Assoc 204:78–83, 1994.
57:E46–E50, 2016. 183. Taylor SS, Goodfellow MR, Browne WJ, et al.: Feline extranodal
162. Hahn KA, Knapp DW, Richardson RC, et al.: Clinical response of lymphoma: response to chemotherapy and survival in 110 cats,
nasal adenocarcinoma to cisplatin chemotherapy in 11 dogs, J Am J Small Anim Pract 50:584–592, 2009.
Vet Med Assoc 200:355–357, 1992. 184. Sfiligoi G, Theon AP, Kent MS: Response of nineteen cats with
163. Langova V, Mutsaers AJ, Phillips B, et al.: Treatment of eight dogs nasal lymphoma to radiation therapy and chemotherapy, Vet Radiol
with nasal tumours with alternating doses of doxorubicin and car- Ultrasound 48:388–393, 2007.
boplatin in conjunction with oral piroxicam, Aust Vet J 82:676– 185. Haney SM, Beaver L, Turrel J, et al.: Survival analysis of 97 cats
680, 2004. with nasal lymphoma: a multi institutional retrospective study
164. London C, Mathie T, Stingle N, et al.: Preliminary evidence for (1986-2006), J Vet Intern Med 23:287–294, 2009.
biologic activity of toceranib phosphate (Palladia ) in solid tumours, 186. Little L, Patel R, Goldschmidt M: Nasal and nasopharyngeal lym-
®
Vet Comp Oncol 10:194–205, 2011. phoma in cats: 50 cases (1989-2005), Vet Pathol 44:885–892,
165. De Vos J, Ramos Vega S, Noorman E, et al.: Primary frontal sinus 2007.
squamous cell carcinoma in three dogs treated with piroxicam com- 187. Greci V, Mortellaro CM, Olivero D, et al.: Inflammatory polyps of
bined with carboplatin or toceranib, Vet Comp Oncol 10:206–213, the nasal turbinates of cats: an argument for designation of feline
2011. mesenchymal nasal hamartoma, J Feline Med Surg 13:213–219,
166. Maglietti F, Tellado M, Olaiz N, et al.: Minimally invasive elec- 2011.
trochemotherapy procedure for treating nasal duct tumors in dogs 188. DeLorenzi D, Bertoncello D, Bottero E: Squash preparation cytol-
using a single needle electrode, Radiol Oncol 51:422–430, 2017. ogy from nasopharyngeal masses in the cat: cytological results
167. Suzuki D, Berkenbrock J, de Oliveira K, et al.: Novel application and histological correlations in 30 cases, J Feline Med Surg 10:
for electrochemotherapy: immersion of nasal cavity in dog, Artif 55–60, 2008.
Organs 41:767–784, 2017. 189. Santagostino SF, Mortellaro CM, Boracchi P, et al.: Feline
168. Mayer-Stankeova S, Fidel J, Wergin MC, et al.: Proton spot scan- upper respiratory tract lymphoma: site, cyto-histology, phe-
ning radiotherapy of spontaneous canine tumors, Vet Radiol Ultra- notype, FeLV expression and prognosis, Vet Pathol 52:
sound 50:314–318, 2009. 250–259, 2015.